In accordance with these findings, we see IL-33 treatment increases IL-5 levels during C. difficile infection, and adoptive transfer of ILC2s causes increased eosinophilia in the colon during C. difficile infection in addition to preventing CDI-associated weight loss and mortality. This evidence concerns the gene IL33 and clostridium difficile infection.